What it argues
The Molecule of More is psychiatrist Daniel Lieberman and writer Michael E. Long's account of how dopamine — a single neurotransmitter — shapes human desire, creativity, addiction, politics, and love. The book's central argument is that dopamine is not the pleasure chemical, as it is commonly described. It is the desire chemical — the system that drives us to pursue what we do not yet have. Once something is possessed or familiar, dopamine steps back and a different set of chemicals (serotonin, oxytocin, endorphins) takes over. This distinction between wanting and having is the book's organizing insight and explains a surprisingly large range of human behavior.
The dopamine system, Lieberman argues, evolved to help us pursue resources in an uncertain environment. It fires in response to the unexpected and quiets when expectations are met. This produces a characteristic asymmetry: we are motivated more intensely by the prospect of getting something than by the experience of having it. This is why romantic attraction fades after the chase, why addicts find the first high impossible to replicate, and why ambitious people never feel they have accomplished enough. The system is not a flaw — it is the engine of exploration, creativity, and long-range planning. But it runs on a grammar of scarcity and novelty that modern environments exploit relentlessly.
What it gets right
- 1.
Dopamine is the desire chemical, not the pleasure chemical. It fires in anticipation of reward and quiets once reward is obtained. The system drives wanting, not having.
- 2.
Unexpected rewards produce the strongest dopamine response. Once an outcome is predictable, dopamine activity decreases. Novelty is fuel for the system.
- 3.
The dopamine system is future-oriented and abstract. It allows humans to plan, imagine, and pursue goals that exist only as possibilities. This is its evolutionary gift.
What it covers
Who wrote it
Daniel Z. Lieberman is a professor of psychiatry at George Washington University School of Medicine and has been practicing clinical psychiatry for over two decades. He has conducted research on dopamine, addiction, and mood disorders, and he treats patients with conditions including depression, bipolar disorder, and substance use disorders. Michael E. Long is a writer and communications consultant who collaborated with Lieberman to translate the neuroscience into narrative form. The Molecule of More, published in 2018, is their first book together and has been translated into over twenty languages.